December 28, 2021
US sees drop in sales of critical antimicrobial drugs approved for use in livestock in 2019-2020 period
US sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals decreased by 3% between 2019 and 2020, according to the US, according to the US Food and Drug Administration (FDA).
This is a 38% decrease since 2015, which was the peak year of sales. This suggests that continued efforts to support the judicious use of antimicrobials in food-producing animals are having an impact.
An estimated 41% of medically important antimicrobials approved for use in food-producing animals by US authorities were for use in swine in 2020.
While sales data on antimicrobial drug products intended for food-producing animals do not necessarily reflect the actual use of antimicrobial drugs, sales volume observed over time can be a valuable indicator of market trends related to these products. FDA recognises that fluctuations in sales volume may occur over time in response to various factors, including changing animal health needs or changes in animal populations.
Given the substantial change that occurred with transitioning a large number of products containing medically important antimicrobials from over-the-counter use to a marketing status requiring veterinary oversight at the beginning of 2017, some rebound in the reported sales volume in subsequent years was not unexpected as affected stakeholders adjusted to the new requirements.
The domestic sales and distribution of medically important antimicrobials approved for use in food-producing animals for 2020 included:
- An estimated 41% was intended for use in cattle;
- An estimated 41% intended for use in swine (2,451,382kg of active ingredient);
- An estimated 12% intended for use in turkeys;
- An estimated 2% intended for use in chickens;
- An estimated 4% intended for use in other species/unknown.